
Why Is Citius Oncology, Inc. (NASDAQ: CTOR) Stock Down Today?
Live update on CTOR's movement on the NASDAQ, with key data on price change, volume, technical indicators, sector trends, and analyst sentiment.
Citius Oncology, Inc. (NASDAQ: CTOR) Update
Citius Oncology, Inc. (NASDAQ: CTOR) Summary
Citius Oncology, Inc. (NASDAQ: CTOR) is trading down -5.45% at $0.74, reflecting a negative shift in investor sentiment today. The stock opened at $0.76 and has moved between $0.72 and $0.76 so far.
Trading volume is 74971, which is 10% below its average, and the price action suggests selling interest.
Technically, CTOR on the NASDAQ is trading above its 50-day moving average of $0.68 and below its 200-day moving average of $0.97, indicating short-term strength but long-term weakness.
Meyka's AI assigns CTOR a grade of C (Overall fair), reflecting its assessment of fundamentals and sentiment. Forecast models project potential returns of -15.93% in 1 month ($0.62), -100.00% in 1 year ($0.00), and -100.00% in 5 years ($0.00).
See full chart, check forecasting details, or see the AI grade breakdown to explore what's driving this stock's movement on the NASDAQ.
Stay informed and make better investment decisions.
CTOR (NASDAQ) Technical Signals
Trading over 50-day moving average ($0.68)
Trading below 200-day moving average ($0.97)
Price Forecast
1 Month
$0.62
1 Year
N/A
3 Years
N/A
5 Years
N/A
Is this change significant?
5-Day:+19.84%
1-Month:+9.26%
3-Month:-16.74%
What's next?
Next earnings date: 7/30/2025